EVRA
Code : EVR01
Price:
Contact
Share this product to others
Shopping
guide
Add to cart
Share this product to friends and family
-
Norelgestromin 6 mg, ethinyl estradiol 600 mcg
-
Thrombophlebitis, thromboembolic disorders or a past history of these conditions; persistent BP ≥160 mmHg systolic or ≥100 mmHg diastolic; cerebrovascular or coronary artery disease; valvular heart disease w/ complications; known thrombophilic conditions; DM w/ vascular involvement; migraine w/ focal aura; known or suspected breast cancer, endometrial cancer or other oestrogen-dependent neoplasia; undiagnosed abnormal genital bleeding; cholestatic jaundice of pregnancy or jaundice w/ prior hormonal contraceptive use; acute or chronic hepatocellular disease w/ abnormal liver function; hepatic adenomas or carcinomas. Pregnancy.
Adverse drugs reaction : Application site reaction, breast symptoms (including breast discomfort, breast engorgement & female breast pain), nausea, headache, emotional lability.
Dosage:
-
Use 1 patch at a time, applied & worn wkly for 3 wk. On change day (day 8 & 15 of the cycle) removed used patch & replace w/ a new one immediately. The 4th wk is patch-free starting on day 22 through day 28.
Detail information: MyPhuocPharmacy-(08) 62581003.
Norelgestromin 6 mg, ethinyl estradiol 600 mcg
Body wt ≥90 kg. Heavy smoking in women >35 yr. Conditions which increase risk of developing VTE complications. Risk factors for arterial disease eg smoking, hyperlipidemia, HTN, obesity or conditions which increase the risk of arterial thromboembolic complications eg SLE; severe migraine w/o aura, DM, severe depression or history of this condition, presence or history of cholelithiasis, chronic idiopathic jaundice, family history of cholestatic jaundice eg Rotor, Dubin-Johnson syndrome. Hepatic neoplasia; reproductive organ & breast carcinoma. Decreased glucose tolerance, bleedi